Personalized neurorehabilitative precision medicine – from data to therapies
Recruiting
- Conditions
- I61I62Intracerebral haemorrhageOther nontraumatic intracranial haemorrhage
- Registration Number
- DRKS00025132
- Lead Sponsor
- eurologische Universitätsklinik und Hertie-Institut für Klinische Hirnforschung
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
18 years
stroke effecting the upper extremity
FMA < 50
Written informed consent
Exclusion Criteria
Subject is not yet 18 year.
Subject has an acute stroke not affecting one UE
FMA over 50
Subject or caregiver does not understand the study and its procedures and gives no informed consent.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of FMA of the opper extremity from acute phase to 90 days after stroke event
- Secondary Outcome Measures
Name Time Method Changes in SS-QOL, mRS, BI and ARAT between acute phase and 90 days stroke event